Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Ekso Bionics Holdings Inc (EKSO) USD0.001

Sell:$4.45 Buy:$4.62 Change: $0.23 (5.31%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Change: $0.23 (5.31%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Change: $0.23 (5.31%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates through two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells and rents exoskeletons for applications in the medical markets. Its leading product in EksoHealth, the EksoNR, is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment. EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Its products include EksoZeroG Arm and and EksoVest. EksoZeroG Arm is a mobile arm mount and EksoVest is an upper body exoskeleton.

Contact details

1414 Harbour Way S Ste 1201
United States
+1 (510) 9841761

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$52.14 million
Shares in issue:
12.66 million
Health Care Equipment
United States
US dollar

Key personnel

  • Steven Sherman
    Executive Chairman of the Board
  • Jack Peurach
    President, Chief Executive Officer, Director
  • John Glenn
    Chief Financial Officer, Secretary
  • Jason Jones
    Vice-President of Product Development
  • William Shaw
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.